Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOCUS: Long-Term Safety of Febuxostat in Gout
NCT00174941Phase 2Completed
- Sponsor
- Takeda
- Start
- Mar 2001
- Primary completion
- Dec 2006
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of febuxostat in gout, sponsored by Takeda. Started Mar 2001; status: completed.
02
Drugs
febuxostat
03
Conditions
gout
Beyond the preview
Go deeper on NCT00174941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00174941.